Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis Inhibition

<i>Candida albicans</i> is the most dominant and prevalent cause of fungal infections in humans. Azoles are considered as first-line drugs for the treatment of these infections. However, their prolonged and insistent use has led to multidrug resistance and treatment failures. To overcome...

Full description

Bibliographic Details
Main Authors: Irfan A. Rather, Jamal S. M. Sabir, Amer H. Asseri, Mohmmad Younus Wani, Aijaz Ahmad
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/8/7/688
_version_ 1797446043252555776
author Irfan A. Rather
Jamal S. M. Sabir
Amer H. Asseri
Mohmmad Younus Wani
Aijaz Ahmad
author_facet Irfan A. Rather
Jamal S. M. Sabir
Amer H. Asseri
Mohmmad Younus Wani
Aijaz Ahmad
author_sort Irfan A. Rather
collection DOAJ
description <i>Candida albicans</i> is the most dominant and prevalent cause of fungal infections in humans. Azoles are considered as first-line drugs for the treatment of these infections. However, their prolonged and insistent use has led to multidrug resistance and treatment failures. To overcome this, modification or derivatization of the azole ring has led to the development of new and effective antifungal molecules. In a previous study, we reported on the development of new triazole-based molecules as potential antifungal agents against <i>Candida auris</i>. In this study, the most potent molecules from the previous study were docked and simulated with lanosterol 14-alpha demethylase enzyme. These compounds were further evaluated for in vitro susceptibility testing against <i>C. albicans</i>. In silico results revealed favorable structural dynamics of the compounds, implying that the compounds would be able to effectively bind to the target enzyme, which was further manifested by the strong interaction of the test compounds with the amino acid residues of the target enzyme. In vitro studies targeting quantification of ergosterol content revealed that pta1 was the most active compound and inhibited ergosterol production by >90% in both drug-susceptible and resistant <i>C. albicans</i> isolates. Furthermore, RT-qPCR results revealed downregulation of <i>ERG11</i> gene when <i>C. albicans</i> cells were treated with the test compound, which aligns with the decreased ergosterol content. In addition, the active triazole derivatives were also found to be potent inhibitors of biofilm formation. Both in silico and in vitro results indicate that these triazole derivatives have the potential to be taken to the next level of antifungal drug development.
first_indexed 2024-03-09T13:34:36Z
format Article
id doaj.art-e2a3791240f54479bd47766b99099b29
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-03-09T13:34:36Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-e2a3791240f54479bd47766b99099b292023-11-30T21:14:10ZengMDPI AGJournal of Fungi2309-608X2022-06-018768810.3390/jof8070688Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis InhibitionIrfan A. Rather0Jamal S. M. Sabir1Amer H. Asseri2Mohmmad Younus Wani3Aijaz Ahmad4Department of Biological Sciences, Faculty of Science, King Abdulaziz University (KAU), Jeddah 21589, Saudi ArabiaDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University (KAU), Jeddah 21589, Saudi ArabiaBiochemistry Department, Faculty of Science, King Abdulaziz University (KAU), Jeddah 21589, Saudi ArabiaDepartment of Chemistry, College of Science, University of Jeddah, Jeddah 21589, Saudi ArabiaClinical Microbiology and Infectious Diseases, Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, Johannesburg 2193, South Africa<i>Candida albicans</i> is the most dominant and prevalent cause of fungal infections in humans. Azoles are considered as first-line drugs for the treatment of these infections. However, their prolonged and insistent use has led to multidrug resistance and treatment failures. To overcome this, modification or derivatization of the azole ring has led to the development of new and effective antifungal molecules. In a previous study, we reported on the development of new triazole-based molecules as potential antifungal agents against <i>Candida auris</i>. In this study, the most potent molecules from the previous study were docked and simulated with lanosterol 14-alpha demethylase enzyme. These compounds were further evaluated for in vitro susceptibility testing against <i>C. albicans</i>. In silico results revealed favorable structural dynamics of the compounds, implying that the compounds would be able to effectively bind to the target enzyme, which was further manifested by the strong interaction of the test compounds with the amino acid residues of the target enzyme. In vitro studies targeting quantification of ergosterol content revealed that pta1 was the most active compound and inhibited ergosterol production by >90% in both drug-susceptible and resistant <i>C. albicans</i> isolates. Furthermore, RT-qPCR results revealed downregulation of <i>ERG11</i> gene when <i>C. albicans</i> cells were treated with the test compound, which aligns with the decreased ergosterol content. In addition, the active triazole derivatives were also found to be potent inhibitors of biofilm formation. Both in silico and in vitro results indicate that these triazole derivatives have the potential to be taken to the next level of antifungal drug development.https://www.mdpi.com/2309-608X/8/7/688triazole derivatives<i>C. albicans</i>ergosterolmolecular dockingsimulation
spellingShingle Irfan A. Rather
Jamal S. M. Sabir
Amer H. Asseri
Mohmmad Younus Wani
Aijaz Ahmad
Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis Inhibition
Journal of Fungi
triazole derivatives
<i>C. albicans</i>
ergosterol
molecular docking
simulation
title Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis Inhibition
title_full Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis Inhibition
title_fullStr Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis Inhibition
title_full_unstemmed Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis Inhibition
title_short Triazole Derivatives Target 14α–Demethylase (LDM) Enzyme in <i>Candida albicans</i> Causing Ergosterol Biosynthesis Inhibition
title_sort triazole derivatives target 14α demethylase ldm enzyme in i candida albicans i causing ergosterol biosynthesis inhibition
topic triazole derivatives
<i>C. albicans</i>
ergosterol
molecular docking
simulation
url https://www.mdpi.com/2309-608X/8/7/688
work_keys_str_mv AT irfanarather triazolederivativestarget14ademethylaseldmenzymeinicandidaalbicansicausingergosterolbiosynthesisinhibition
AT jamalsmsabir triazolederivativestarget14ademethylaseldmenzymeinicandidaalbicansicausingergosterolbiosynthesisinhibition
AT amerhasseri triazolederivativestarget14ademethylaseldmenzymeinicandidaalbicansicausingergosterolbiosynthesisinhibition
AT mohmmadyounuswani triazolederivativestarget14ademethylaseldmenzymeinicandidaalbicansicausingergosterolbiosynthesisinhibition
AT aijazahmad triazolederivativestarget14ademethylaseldmenzymeinicandidaalbicansicausingergosterolbiosynthesisinhibition